A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:97 |
|---|---|
| Enthalten in: |
American journal of hematology - 97(2022), 2 vom: 01. Feb., Seite E54-E58 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cornell, Robert Frank [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 10.02.2022 Date Revised 29.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ajh.26420 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333550889 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333550889 | ||
| 003 | DE-627 | ||
| 005 | 20240229233936.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ajh.26420 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM333550889 | ||
| 035 | |a (NLM)34817872 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cornell, Robert Frank |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.02.2022 | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial, Phase I | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Eltanexor |2 NLM | |
| 700 | 1 | |a Baz, Rachid |e verfasserin |4 aut | |
| 700 | 1 | |a Richter, Joshua R |e verfasserin |4 aut | |
| 700 | 1 | |a Rossi, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Vogl, Dan T |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Shustik, Chaim |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarez, Mariano J |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Yao |e verfasserin |4 aut | |
| 700 | 1 | |a Unger, T J |e verfasserin |4 aut | |
| 700 | 1 | |a Ben-Shahar, Osnat |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Hongwei |e verfasserin |4 aut | |
| 700 | 1 | |a Baloglu, Erkan |e verfasserin |4 aut | |
| 700 | 1 | |a Senapedis, William |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Xiwen |e verfasserin |4 aut | |
| 700 | 1 | |a Landesman, Yosef |e verfasserin |4 aut | |
| 700 | 1 | |a Bai, Xiang |e verfasserin |4 aut | |
| 700 | 1 | |a Bader, Justin |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Hongmei |e verfasserin |4 aut | |
| 700 | 1 | |a Marshall, Tracey |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, Hua |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Jatin |e verfasserin |4 aut | |
| 700 | 1 | |a Shacham, Sharon |e verfasserin |4 aut | |
| 700 | 1 | |a Kauffman, Michael G |e verfasserin |4 aut | |
| 700 | 1 | |a Hofmeister, Craig C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of hematology |d 1993 |g 97(2022), 2 vom: 01. Feb., Seite E54-E58 |w (DE-627)NLM000124354 |x 1096-8652 |7 nnns |
| 773 | 1 | 8 | |g volume:97 |g year:2022 |g number:2 |g day:01 |g month:02 |g pages:E54-E58 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ajh.26420 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 97 |j 2022 |e 2 |b 01 |c 02 |h E54-E58 | ||